Literature DB >> 26838909

Mesoporous silica nanoparticles with bilayer coating of poly(acrylic acid-co-itaconic acid) and human serum albumin (HSA): A pH-sensitive carrier for gemcitabine delivery.

Ali Pourjavadi1, Zahra Mazaheri Tehrani2.   

Abstract

Novel bilayer coated mesoporous silica nanoparticle (MCM-41) based on pH sensitive poly(acrylic acid-co-itaconic acid) and human serum albumin (HSA) was designed for controlled delivery of gemcitabine (anticancer drug) to cancer cells. The shell around the mesoporous silica has bilayer structure. Poly(acrylic acid-co-itaconic acid) was used as pH-sensitive inner shell and human serum albumin, HSA, was used as outer shell. The core-shell structure was formed due to electrostatic interaction between ammonium groups of modified MCM-41 and carboxylate groups of copolymer. Also, the albumin layer was wrapped around the copolymer coated nanoparticle by electrostatic interaction between ammonium groups from protein and carboxylate ions of copolymer shell. Moreover, the maximum release occurred at pH 5.5 (pH of endosomes) because the bilayer shell collapsed at this pH. The drug nanocarrier would be a good candidate for tumor therapy due to its biocompatibility, controlled release and pH responsive behavior.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Human serum albumin; Mesoporous silica nanoparticle; Poly(acrylic acid-co-itaconic acid); pH-sensitive carrier

Mesh:

Substances:

Year:  2016        PMID: 26838909     DOI: 10.1016/j.msec.2015.12.096

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  7 in total

Review 1.  How Advancing are Mesoporous Silica Nanoparticles? A Comprehensive Review of the Literature.

Authors:  Sahar Porrang; Soodabeh Davaran; Nader Rahemi; Somaiyeh Allahyari; Ebrahim Mostafavi
Journal:  Int J Nanomedicine       Date:  2022-04-22

Review 2.  pH-Responsive Mesoporous Silica and Carbon Nanoparticles for Drug Delivery.

Authors:  Miguel Gisbert-Garzarán; Miguel Manzano; María Vallet-Regí
Journal:  Bioengineering (Basel)       Date:  2017-01-18

3.  Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer.

Authors:  Na Qu; Robert J Lee; Yating Sun; Guangsheng Cai; Junyang Wang; Mengqiao Wang; Jiahui Lu; Qingfan Meng; Lirong Teng; Di Wang; Lesheng Teng
Journal:  Int J Nanomedicine       Date:  2016-07-26

4.  Biotin-Decorated PAMAM G4.5 Dendrimer Nanoparticles to Enhance the Delivery, Anti-Proliferative, and Apoptotic Effects of Chemotherapeutic Drug in Cancer Cells.

Authors:  Endiries Yibru Hanurry; Tefera Worku Mekonnen; Abegaz Tizazu Andrgie; Haile Fentahun Darge; Yihenew Simegniew Birhan; Wei-Hsin Hsu; Hsiao-Ying Chou; Chih-Chia Cheng; Juin-Yih Lai; Hsieh-Chih Tsai
Journal:  Pharmaceutics       Date:  2020-05-11       Impact factor: 6.321

5.  Preparation of RGD Peptide/Folate Acid Double-Targeted Mesoporous Silica Nanoparticles and Its Application in Human Breast Cancer MCF-7 Cells.

Authors:  Huijie Yan; Yun You; Xinjian Li; Lei Liu; Fengqian Guo; Qiongling Zhang; Dewen Liu; Yan Tong; Shilan Ding; Jinyu Wang
Journal:  Front Pharmacol       Date:  2020-06-16       Impact factor: 5.810

6.  An intelligent responsive macrophage cell membrane-camouflaged mesoporous silicon nanorod drug delivery system for precise targeted therapy of tumors.

Authors:  Minghua Li; Xiaolong Gao; Chao Lin; Aijun Shen; Jing Luo; Qiongqiong Ji; Jiaqi Wu; Peijun Wang
Journal:  J Nanobiotechnology       Date:  2021-10-24       Impact factor: 10.435

Review 7.  Influence of the Surface Functionalization on the Fate and Performance of Mesoporous Silica Nanoparticles.

Authors:  Miguel Gisbert-Garzarán; María Vallet-Regí
Journal:  Nanomaterials (Basel)       Date:  2020-05-09       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.